Actualités

Zacks17d agobullish

IDEX Beats Q1 Earnings Estimates on HST Momentum, Raises View

IEX beats Q1 estimates and raises outlook as strong Health & Science Technologies demand and record orders signal momentum into 2026.

MarketBeat17d agoneutral

IDEX Q1 Earnings Call Highlights

IDEX (NYSE:IEX) reported first-quarter 2026 results that management said came in above expectations, supported by growth in its targeted “advantage markets” and continued application of the company’s 80/20 operating philosophy. Quarterly performance and orders President and CEO Eric Ashleman said I

Motley Fool18d agoneutral

IDEX (IEX) Q1 2026 Earnings Call Transcript

IDEX delivered a strong first quarter and continue to see our growth strategies gain traction as we expand and integrate capabilities in targeted advantaged markets powered by 8020. In the first quarter, IDEX delivered organic sales growth of 5% and adjusted EBITDA margin of 26%, which reflects a margin expansion of 50 basis points year-over-year. Strength was most pronounced in our Health & Science Technologies, or HST segment, where secular drivers continue to fuel growth across high-value applications in data center, semiconductor and space and defense markets.

IEX

Zacks18d agoneutral

Idex (IEX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

IEX

Zacks18d agoneutral

Idex (IEX) Q1 Earnings and Revenues Top Estimates

Idex (IEX) delivered earnings and revenue surprises of +12.68% and +6.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

IEX